AVTXNasdaq United States
Market cap
$969.183 M
$18.32 -2.03%
Close of 7 Aug 2026
Revenue
$59.0K
#3628 by revenue
Earnings
-$78.3M
Loss-making
Shares outstanding
53,629,989
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Avalo Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.